2020
Pharmacology
Amin H, Schindler J. Pharmacology. 2020, 235-241. DOI: 10.1007/978-3-030-52552-1_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacologyEpidemiology and Risk Factors
Amin H, Schindler J. Epidemiology and Risk Factors. 2020, 49-55. DOI: 10.1007/978-3-030-52552-1_5.ChaptersRisk factorsStroke riskNon-modifiable risk factorsIndividual stroke riskSignificant global health burdenModifiable risk factorsGlobal health burdenPutative risk factorsStroke physiciansInsulin resistanceOutpatient settingHealth burdenFuture burdenStrokeBurdenRiskFactorsInternistsEpidemiologyPhysiciansTrials
2016
Pharmacology
Amin H, Schindler J. Pharmacology. 2016, 177-183. DOI: 10.1007/978-3-319-39605-7_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacologyEpidemiology and Risk Factors
Amin H, Schindler J. Epidemiology and Risk Factors. 2016, 37-42. DOI: 10.1007/978-3-319-39605-7_5.ChaptersRisk factorsStroke riskIndividual stroke riskSignificant global health burdenModifiable risk factorsNonmodifiable risk factorsGlobal health burdenPutative risk factorsStroke physiciansInsulin resistanceOutpatient settingHealth burdenFuture burdenStrokeBurdenRiskFactorsInternistsEpidemiologyPhysiciansTrials